Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi Clinical Oncology: Case Reports
Guy-Armel Bounda (China) Author
Subjects of specialization
Affiliation
Anticoagulation,Patient education,Thrombosis,Phytotherapy,Clinical Pharmacy
Professor China Pharmaceutical University, China
Biography
I hold a PhD in Clinical Pharmacy awarded in 2015 from the Prestigious China Pharmaceutical University. Wherever in Academia, Research, Clinic or Industry, I am a strongly rigorous and analytical person with a proven record of research and clinical skills. As a scientist and clinical pharmacist, I am working currently at SINOMEDICA CO., LTD (Nanjing, China) as a biomedical advisor and Drug Expert. Meanwhile, in the same time I am working as a preceptor at Department of Clinical pharmacy, School of Basic Medicine and Clinical Pharmacy at China Pharmaceutical University, Nanjing China as I offer my expertise to International Students.
Publications
Review Article Open Access
Phytotherapy of Prostate Cancer: How far are we?
Author(s): Guy-Armel Bounda (China)
Prostate cancer (PCa) is the second most diagnosed cancer in men, principally affecting men over 50 years old, and is the fifth leading cause of cancer-related deaths in men worldwide. In recent years, the use of complementary and alternative medicine (CAM) has increased, especially among oncology patients. Treatment options are limited in androgen-independent prostate cancer. To reduce this tremendous health burden, new approaches have been directed toward extremes of the disease spectrum centering on strategies for prostate cancer prevention and for treating advanced androgen-independent cancers. Medicinal herbs and their derivative phytocompounds are being increasingly recognized as useful complementary treatments for cancer. Great number of clinical studies have reported the benefic... view more»
Social Media
Google Scholars / Researchers Sites
